Lobbying Spend
—
Filings
35
Firms Hired
2
Active Period
2015–2025
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
National Defense Authorization Act for Fiscal Year 2025
2024 · fourth_quarter · Firm: DLA PIPER LLP (US)
S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.
Client expense: — · Firm income: $10,000
Matched citations: S. 4638
Department of Defense Appropriations Act, 2025
2024 · fourth_quarter · Firm: DLA PIPER LLP (US)
S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.
Client expense: — · Firm income: $10,000
Matched citations: S. 4921
National Defense Authorization Act for Fiscal Year 2025
2024 · third_quarter · Firm: DLA PIPER LLP (US)
S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.
Client expense: — · Firm income: $10,000
Matched citations: S. 4638
Department of Defense Appropriations Act, 2025
2024 · third_quarter · Firm: DLA PIPER LLP (US)
S. 4921, Department of Defense Appropriations Act, FY2025, provisions related to biologic vascular research. S. 4638, National Defense Authorization Act for FY2025, provisions related to biologic vascular research.
Client expense: — · Firm income: $10,000
Matched citations: S. 4921
Source: Senate LDA